Is nose-to-brain transport of drugs in man a reality?ILLUM, Lisbeth.Journal of pharmacy and pharmacology. 2004, Vol 56, Num 1, pp 3-17, issn 0022-3573, 15 p.Article

Nasal drug delivery: new developments and strategiesILLUM, Lisbeth.Drug discovery today. 2002, Vol 7, Num 23, pp 1184-1189, issn 1359-6446, 6 p.Article

Nanoparticulate systems for nasal delivery of drugs : A real improvement over simple systems?ILLUM, Lisbeth.Journal of pharmaceutical sciences. 2007, Vol 96, Num 3, pp 473-483, issn 0022-3549, 11 p.Article

Nasal drug delivery — Recent developments and future prospectsILLUM, Lisbeth.Journal of controlled release. 2012, Vol 161, Num 2, pp 254-263, issn 0168-3659, 10 p.Article

Nanoparticles for direct nose-to-brain delivery of drugsMISTRY, Alpesh; STOLNIK, Snjezana; ILLUM, Lisbeth et al.International journal of pharmaceutics (Print). 2009, Vol 379, Num 1, pp 146-157, issn 0378-5173, 12 p.Article

CriticalSorb™: A novel efficient nasal delivery system for human growth hormone based on Solutol HS15ILLUM, Lisbeth; JORDAN, Faron; LEWIS, Andrew L et al.Journal of controlled release. 2012, Vol 162, Num 1, pp 194-200, issn 0168-3659, 7 p.Article

Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous systemCHARLTON, Stuart T; DAVIS, Stanley S; ILLUM, Lisbeth et al.Journal of drug targeting. 2007, Vol 15, Num 5, pp 370-377, issn 1061-186X, 8 p.Article

Nasal drug delivery: possibilities, problems and solutionsILLUM, Lisbeth.Journal of controlled release. 2003, Vol 87, Num 1-3, pp 187-198, issn 0168-3659, 12 p.Conference Paper

Intranasal delivery: Physicochemical and therapeutic aspectsCOSTANTINO, Henry R; ILLUM, Lisbeth; BRANDT, Gordon et al.International journal of pharmaceutics. 2007, Vol 337, Num 1-2, pp 1-24, issn 0378-5173, 24 p.Article

Effect of PEGylation on the Toxicity and Permeability Enhancement of ChitosanCASETTARI, Luca; VILASALIU, Driton; MANTOVANI, Giuseppe et al.Biomacromolecules. 2010, Vol 11, Num 11, pp 2854-2865, issn 1525-7797, 12 p.Article

Drug-polyionic block copolymer interactions for micelle formation : physicochemical characterisationGOVENDER, Thirumala; STOLNIK, Snjezana; CHENGDONG XIONG et al.Journal of controlled release. 2001, Vol 75, Num 3, pp 249-258, issn 0168-3659Article

Surface Characterisation of Bioadhesive PLGA/Chitosan Microparticles Produced by Supercritical Fluid TechnologyCASETTARI, Luca; CASTAGNINO, Enzo; STOLNIK, Snjezana et al.Pharmaceutical research. 2011, Vol 28, Num 7, pp 1668-1682, issn 0724-8741, 15 p.Article

PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applicationsCASETTARI, Luca; VLLASALIU, Driton; CASTAGNINO, Enzo et al.Progress in polymer science. 2012, Vol 37, Num 5, pp 659-685, issn 0079-6700, 27 p.Article

Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticlesWU LIN; GARNETT, Martin C; DAVIS, Stanley S et al.Journal of controlled release. 2001, Vol 71, Num 1, pp 117-126, issn 0168-3659Article

Polymeric lamellar substrate particles for intranasal vaccinationJABBAL-GILL, Inderjit; WU LIN; KISTNER, Otfried et al.Advanced drug delivery reviews. 2001, Vol 51, Num 1-3, pp 97-111, issn 0169-409XArticle

A mucosal vaccine against diphtheria : formulation of cross reacting material (CRM₁₉₇) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryMCNEELA, Edel A; O'CONNOR, David; JABBAL-GILL, Inderjit et al.Vaccine. 2000, Vol 19, Num 9-10, pp 1188-1198, issn 0264-410XArticle

Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat ModelCHARLTON, Stuart T; WHETSTONE, Joanne; FAYINKA, Susan T et al.Pharmaceutical research. 2008, Vol 25, Num 7, pp 1531-1543, issn 0724-8741, 13 p.Article

Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosanMCNEELA, Edel A; JABBAL-GILL, Inderjit; ILLUM, Lisbeth et al.Vaccine. 2004, Vol 22, Num 8, pp 909-914, issn 0264-410X, 6 p.Article

Stability of Human Growth Hormone in Supercritical Carbon DioxideKELLY, Catherine A; HOWDLE, Steven M; NAYLOR, Andrew et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 1, pp 56-67, issn 0022-3549, 12 p.Article

Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solutionVLLASALIU, Driton; EXPOSITO-HARRIS, Ruth; HERAS, Angeles et al.International journal of pharmaceutics (Print). 2010, Vol 400, Num 1-2, pp 183-193, issn 0378-5173, 11 p.Article

Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epitheliumMISTRY, Alpesh; GLUD, Sys Zoffmann; KJEMS, Jorgen et al.Journal of drug targeting. 2009, Vol 17, Num 7, pp 543-552, issn 1061-186X, 10 p.Article

Effective nasal influenza vaccine delivery using chitosanREAD, Robert C; NAYLOR, Simone C; POTTER, Christopher W et al.Vaccine. 2005, Vol 23, Num 35, pp 4367-4374, issn 0264-410X, 8 p.Article